Scott Kaufman, aka Treading Softly, learned about investing firsthand from over a decade of financial sector experience. He is the lead analyst for Dividend Kings providing actionable insight into high quality dividend growing and undervalued opportunities. His focus is to see a bountiful harvest of cash dividends and strong capital gains, providing a robust total return. Analyst's Disclosure:I/we have a beneficial long position in the shares of CI either through stock ownership, options, or other derivativ ...

NANO Nuclear Announces 1 GW Feasibility Study with BaRupOn LLC., a Technology Driven American Manufacturing Company NANO Nuclear will be compensated for completing a feasibility study to evaluate siting many KRONOS MMR units to generate 1 GW of energy across BaRupOn's Liberty American Multi-Sourced Power and Innovation Hub in development in Texas November 24, 2025 7:59 AM EST | Source: NANO Nuclear Energy Inc. New York, New York--(Newsfile Corp. - November 24, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ...

Core Viewpoint - Novo Nordisk's shares experienced a significant decline after the failure of its trials testing the impact of Ozempic on Alzheimer's disease progression, marking the lowest level since July 2021 [1][2]. Group 1: Stock Performance - Shares of Novo Nordisk fell by more than 12% initially, recovering slightly to Kr 273.35 ($42.25), which represents a decrease of approximately 10.3% [1]. - The company's stock has decreased by 57.2% since the beginning of 2025 and is over 72% lower than its peak in June 2024, when it reached Kr 1,000 ($154.5) [4]. Group 2: Trial Results - The trials involved 3,808 adults and aimed to assess the effect of semaglutide, the active ingredient in Ozempic, on Alzheimer's disease progression, but did not meet their primary goal [2]. - Cognitive assessments indicated that patients receiving semaglutide did not show significant slowing in disease progression compared to the placebo group [2]. - Despite showing "improvement of Alzheimer's disease-related biomarkers" in both trials, the drug failed to slow the neurodegenerative disease [3]. - The trials targeted patients aged 55 to 85 with mild cognitive impairment or mild dementia due to Alzheimer's disease, and the company will discontinue a planned one-year extension of the studies [3].

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or ...

- Upon the closing of the private placement, Enlivex will adopt the world's first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. BTIG is serving as the sole placement agent and exclusive financial advisor for the Transaction. Greenberg Traurig, P.A. and FISCHER (FBC & Co.) serve as legal counsels to Enlivex, and DLA Piper and Gornitzky & Co. serve as legal counsels to BTIG. This press release shall not constitute an offer to sell, or the solicitation of an offer ...

Core Viewpoint - The potential Federal Reserve rate cut in December is anticipated to stimulate a 'risk-on' sentiment in the market, drawing parallels to the market conditions of early 1999 [1] Group 1: Market Sentiment - A rate cut could lead to increased investor confidence and a shift towards riskier assets, similar to the late 1990s tech boom [1] - Current market indicators suggest a growing appetite for equities, reflecting a shift in sentiment towards a more optimistic outlook [1] Group 2: Economic Indicators - Economic data releases are being closely monitored, with expectations that a rate cut could support economic growth and consumer spending [1] - Analysts are observing trends in inflation and employment figures, which will influence the Fed's decision-making process [1] Group 3: Historical Context - The comparison to early 1999 highlights the cyclical nature of markets, where low interest rates can lead to speculative investments [1] - Historical precedents suggest that similar monetary policy actions have previously resulted in significant market rallies [1]

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Green Dot Corporation (NYSE: GDOT) to Smith Ventures and CommerceOne Financial Corporation for $8.11 in cash and 0.2215 shares of a new publicly traded bank holding company for each share of Green Dot is fair to Green Dot shareholders. Halper Sadeh encourages Green Dot shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halpe. ...

Accessibility StatementSkip Navigation CUMMING, Ga., Nov. 24, 2025 /PRNewswire/ --Â Metavesco, Inc. (OTC: MVCO), a diversified holding company and developer of the OTCfi ecosystem, today announced a series of material updates related to its corporate strategy, capital structure, and development roadmap for its OTCfi ecosystem during a livestream broadcast hosted by CEO Ryan Schadel. The full livestream is available for replay here:https://x.com/CRyanSchadel/status/1992730226263310480?s=20 During the two-hou ...

Core Points - The article discusses the identity and professional background of the blogger known as Ironman, who operates on the Political Calculations site, focusing on investing, business, and economics [1] Group 1 - Ironman is described as potentially having multiple professions, including engineer, researcher, analyst, rocket scientist, editor, and teacher [1] - The article suggests that Ironman may not be a single individual, leaving it to readers to determine the true identity behind the posts and comments [1]

Core Insights - Proactive is a financial news publisher that provides fast, accessible, and actionable business and finance news to a global investment audience [2][3] - The company focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive employs a team of experienced journalists and utilizes technology, including automation and generative AI, to enhance content production while ensuring human oversight [4][5] Company Overview - Proactive operates editorial and broadcast operations across six offices on three continents, producing approximately 50,000 pieces of news and feature content annually [1] - The news team is strategically located in key finance and investing hubs, including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Content Focus - The company delivers news and insights across various sectors, including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3]